HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early Percutaneous Tracheostomy in Coronavirus Disease 2019: Association With Hospital Mortality and Factors Associated With Removal of Tracheostomy Tube at ICU Discharge. A Cohort Study on 121 Patients.

AbstractOBJECTIVES:
Early tracheotomy, defined as a procedure performed within 10 days from intubation, is associated with more ventilator free days, shorter ICU stay, and lower mortality than late tracheotomy. During the coronavirus disease 2019 pandemic, it was especially important to save operating room resources and to have a shorter ICU stay for patients, when ICUs had insufficient beds. In this context of limited resources, early percutaneous tracheostomy could be an effective way to manage mechanically ventilated patients. Nevertheless, current recommendations suggest delaying or avoiding the tracheotomy in coronavirus disease 2019 patients. Aim of the study was to analyze the hospital mortality of coronavirus disease 2019 patients who had received early percutaneous tracheostomy and factors associated with removal of tracheostomy cannula at ICU discharge.
DESIGN:
Cohort study.
SETTING: PATIENTS:
Adult patients with coronavirus disease 2019 3 days after ICU admission.
INTERVENTIONS:
None.
MEASUREMENTS AND MAIN RESULTS:
Three days after ICU admission, 164 patients were present in ICU and included in the analysis. One-hundred and twenty-one patients (74%) were tracheostomized, whereas the other 43 (26%) were managed with translaryngeal intubation only. In multivariable analysis, early percutaneous tracheostomy was associated with lower hospital mortality. Sixty-six of tracheostomized patients (55%) were discharged alive from the hospital. Age and male sex were the only characteristics that were independently associated with mortality in the tracheostomized patients (45.5% and 62.8% in tracheostomized and nontracheostomized patients, respectively; p = 0.009). Tracheostomy tube was removed in 47 of the tracheostomized patients (71%). The only variable independently associated with weaning from tracheostomy at ICU discharge was a faster start of spontaneous breathing after tracheotomy was performed.
CONCLUSIONS:
Early percutaneous tracheostomy was safe and effective in coronavirus disease 2019 patients, giving a good chance of survival and of weaning from tracheostomy cannula at ICU discharge.
AuthorsAntonio Rosano, Enrico Martinelli, Federica Fusina, Filippo Albani, Rosalba Caserta, Alessandro Morandi, Piera Dell'Agnolo, Alessandra Dicembrini, Leila Mansouri, Andrea Marchini, Valeria Schivalocchi, Giuseppe Natalini
JournalCritical care medicine (Crit Care Med) Vol. 49 Issue 2 Pg. 261-270 (02 01 2021) ISSN: 1530-0293 [Electronic] United States
PMID33201005 (Publication Type: Journal Article)
CopyrightCopyright © 2020 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Topics
  • Adult
  • Aged
  • COVID-19 (mortality, therapy)
  • Cohort Studies
  • Critical Illness (mortality)
  • Female
  • Hospital Mortality
  • Humans
  • Intensive Care Units (statistics & numerical data)
  • Italy
  • Length of Stay (statistics & numerical data)
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Respiration, Artificial (mortality)
  • Survival Analysis
  • Tracheostomy (mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: